NasdaqGS - Nasdaq Real Time Price USD

LifeStance Health Group, Inc. (LFST)

13.43 +0.03 (+0.26%)

As of 9:38:50 AM EDT. Market Open.

Trade LFST on Coinbase

Chart Range Bar

Advanced Chart

AlphaSpace Chart

Loading chart for LFST

Previous Close 13.39
Open 13.46
Bid 9.54 x 200
Ask 17.28 x 200
Day's Range 13.33 - 13.47
52 Week Range 4.77 - 13.62
Volume 26,404
Avg. Volume 4,397,229
Market Cap (intraday) 5.104B
Beta (5Y Monthly) 1.24
PE Ratio (TTM) 102.54
EPS (TTM) 0.13
Earnings Date Nov 5, 2026
Forward Dividend & Yield -- (0.00%)
1y Target Est 14.45
Zacks Rating Neutral

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

lifestance.com

8,542

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Care Facilities

Industry

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LFST

89.35%

S&P 500 (^GSPC)

12.51%

1-Year Return

LFST

167.67%

S&P 500 (^GSPC)

11.77%

3-Year Return

LFST

136.77%

S&P 500 (^GSPC)

87.06%

5-Year Return

LFST

11.27%

S&P 500 (^GSPC)

67.24%

Earnings Per Share

gaap GAAP

nongaap Normalized

gaap GAAP

nongaap Normalized

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY26

Revenue 435.35M

Earnings 23.61M

Profit Margin 5.42%

FY25

FY26

100M

200M

300M

400M

1.0%

2.0%

3.0%

4.0%

5.0%

Analyst Price Targets

12.00 Low

14.45 Average

13.43 Current

18.00 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Latest Rating

Date 10/5/2026

Analyst Keybanc

Rating Action Maintains

Rating Overweight

Price Action Raises

Price Target 13 -> 15

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

3.19%
Return on Assets (ttm)

2.32%
Return on Equity (ttm)

3.43%
Revenue (ttm)

1.58B
Net Income Avi to Common (ttm)

50.6M
Diluted EPS (ttm)

0.13

Balance Sheet and Cash Flow

Total Cash (mrq)

225.94M
Total Debt/Equity (mrq)

32.10%
Levered Free Cash Flow (ttm)

172.36M

PRVA Privia Health Group, Inc.

22.12 +1.26%

ALHC Alignment Healthcare, Inc.

8.18 0.00%

FLYW Flywire Corporation

18.88 -0.29%

EVCM EverCommerce Inc.

9.30 -0.96%

SHC Sotera Health Company

18.76 +0.56%

U.S. markets close in 6h 14m

LifeStance Health Group, Inc. (LFST)

Trading disclosure

6.13%

12.11%

79.41%

89.35%

167.67%

11.27%

-33.35%

LifeStance Health Group, Inc. Overview Medical Care Facilities / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Latest Rating

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch